A5090799220- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- Infective Endocarditis Diagnosis and Management
- Cardiac Arrhythmias and Treatments
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Cardiac Structural Anomalies and Repair
- Acute Myocardial Infarction Research
- Aortic Disease and Treatment Approaches
- Coronary Interventions and Diagnostics
- Cardiac pacing and defibrillation studies
- Cardiac, Anesthesia and Surgical Outcomes
- Acute Ischemic Stroke Management
- Mechanical Circulatory Support Devices
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac and Coronary Surgery Techniques
- Heart Failure Treatment and Management
- Cerebrovascular and Carotid Artery Diseases
- Cardiac tumors and thrombi
- Coronary Artery Anomalies
- Cardiovascular and Diving-Related Complications
- Congenital Heart Disease Studies
- Central Venous Catheters and Hemodialysis
Mayo Clinic in Arizona
2016-2025
Mayo Clinic
2016-2025
Mayo Clinic Hospital
2020-2025
WinnMed
2017-2025
Mayo Clinic in Florida
2016-2024
Rochester General Hospital
2023
West Virginia University
2016-2022
Johns Hopkins Medicine
2021
Johns Hopkins University
2021
Michigan Technological University
2021
In ST-segment-elevation myocardial infarction (STEMI), infarct size correlates directly with heart failure and mortality. Preclinical testing has shown that, in comparison reperfusion alone, mechanically unloading the left ventricle (LV) before reduces that 30 minutes of activates a cardioprotective program limits injury. The DTU-STEMI pilot trial (Door-To-Unload STEMI Pilot Trial) represents first exploratory study whether LV delayed patients without cardiogenic shock is safe feasible.In...
Background Tricuspid regurgitation ( TR ), if untreated, is associated with an adverse impact on long‐term outcomes. In recent years, there has been increasing enthusiasm about surgical and transcatheter treatment of patients severe . We aim to evaluate the contemporary trends in use outcomes tricuspid valve (TV) surgery for using National Inpatient Sample. Methods Results Between January 1, 2003 December 31, 2014, estimated 45 477 underwent TV United States, whom 15% had isolated 85%...
Data on the contemporary changes in risk profile and outcomes of patients undergoing percutaneous coronary intervention (PCI) or bypass grafting (CABG) are limited.To assess trends characteristics PCI CABG United States.This retrospective cohort study used a national inpatient claims-based database to identify from January 1, 2003, December 31, 2016. analysis was performed July 15 October 4, 2019.Demographic characteristics, prevalence factors, clinical presentation divided into 3 eras...
Background Studies assessing the differential impact of sex on outcomes aortic valve replacement ( AVR ) yielded conflicting results. We sought to investigate sex‐related differences in utilization, patient risk profile, and in‐hospital using Nationwide Inpatient Sample. Methods Results In total, 166 809 patients (63% male 37% female) who underwent between 2003 2014 were identified, 48.5% had a concomitant cardiac surgery procedure. Compared with men, women older more nonatherosclerotic...
To confirm whether a relationship exists between male sex and coronavirus disease 2019 (COVID-19) mortality this is age dependent.We queried the COVID-19 Research Network, multinational database using TriNetX network, to identify patients with confirmed infection. The main end point of study was all-cause mortality.A total 14,712 were included, whom 6387 (43%) men. Men older (mean age, 55.0±17.7 years vs 51.1±17.9 years; P<.001) had higher prevalence hypertension, diabetes, coronary disease,...
The aim of this study was to evaluate the outcome transcatheter mitral valve repair (TMVr) in patients with cardiogenic shock and significant regurgitation (MR). Patients severe MR have a poor prognosis setting conventional medical therapy. Because its favorable safety profile, TMVr is being increasingly used as an acute therapy population, though efficacy remains unknown. A multicenter, collaborative, patient-level analysis conducted. moderate (3+) or (4+) who were not surgical candidates...
Abstract Aims To assess the contemporary trends in aortic stenosis (AS) interventions USA before and after introduction of transcatheter valve implantation (TAVI). Methods results We utilized National-Inpatient-Sample to temporal incidence, cost, outcomes AS between 1 January 2003 31 December 2016. During study’s period, increased from 96 137 per 100 000 individuals &gt; 60 years old, P &lt; 0.001. In-hospital expenditure on $2.28 billion $4.33 2016 Among patients who underwent...